Flu Stocks List


Related Industries: Aerospace & Defense Agricultural Inputs Asset Management Auto Parts Banks - Global Banks - Regional - US Biotechnology Building Materials Business Services Chemicals Confectioners Conglomerates Credit Services Diagnostics & Research Diversified Industrials Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Electronic Components Engineering & Construction Farm & Construction Equipment Grocery Stores Health Information Services Home Furnishings & Fixtures Household & Personal Products Industrial Distribution Industrial Electrical Equipment Industrial Metals & Minerals Insurance - Life Internet Content & Information Internet Content & Information Lumber & Wood Production Marketing Services Medical Care Medical Devices Medical Distribution Medical Instruments & Supplies Metal Fabrication Oil & Gas Drilling Oil & Gas Equipment & Services Oil & Gas Integrated Oil & Gas Refining & Marketing Paper & Paper Products Pollution & Treatment Controls Savings & Cooperative Banks Scientific & Technical Instruments Semiconductor Equipment & Materials Software - Application Specialty Chemicals Specialty Retail Tobacco Tools & Accessories Waste Management

Related ETFs - A few ETFs which own one or more of the above listed Flu stocks.

Flu Stocks Recent News

Date Stock Title
Sep 29 RPM Wall Street Breakfast: The Week Ahead
Sep 28 MMM Is 3M Company (MMM) Best Performing Dow Stock in 2024?
Sep 27 SNY Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
Sep 27 SNY Regeneron/ Sanofi granted FDA label expansion for Dupixent in COPD
Sep 27 SNY Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
Sep 27 SNY Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Sep 27 SNY Sanofi, Regeneron get additional Chinese approval for Dupixent
Sep 27 SNY Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
Sep 27 SNY Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD
Sep 27 SNY Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Sep 27 FITB Fifth Third Named a 2024 Leading Disability Employer by the National Organization on Disability
Sep 27 RPM What Analyst Projections for Key Metrics Reveal About RPM International (RPM) Q1 Earnings
Sep 27 SNY Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Sep 27 SNY Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
Sep 27 SNY FDA, after delay, clears Regeneron and Sanofi drug for COPD
Sep 27 TMO Thermo Fisher Scientific Inc. (TMO): Why Are Billionaires Bullish on This Stock Right Now?
Sep 26 CBT Cabot's Stock Rises 16% in Three Months: What's Driving the Rally?
Sep 26 SNY Are Investors Undervaluing Sanofi (SNY) Right Now?
Sep 26 SNY Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
Sep 26 MMM 3M's "Clash of the Grinders" returns: New season of welding and metalworking competition streaming now